Iterum Therapeutics PLC
NASDAQ:ITRM
Iterum Therapeutics PLC
Tax Provision
Iterum Therapeutics PLC
Tax Provision Peer Comparison
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Iterum Therapeutics PLC
NASDAQ:ITRM
|
Tax Provision
-$613k
|
CAGR 3-Years
6%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
Perrigo Company PLC
NYSE:PRGO
|
Tax Provision
$3.9m
|
CAGR 3-Years
-53%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
Tax Provision
$92.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
Tax Provision
$501k
|
CAGR 3-Years
-45%
|
CAGR 5-Years
-51%
|
CAGR 10-Years
-27%
|
|
G
|
GH Research PLC
NASDAQ:GHRS
|
Tax Provision
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
Tax Provision
-€6.3m
|
CAGR 3-Years
-86%
|
CAGR 5-Years
-60%
|
CAGR 10-Years
-8%
|
See Also
What is Iterum Therapeutics PLC's Tax Provision?
Tax Provision
-613k
USD
Based on the financial report for Dec 31, 2023, Iterum Therapeutics PLC's Tax Provision amounts to -613k USD.
What is Iterum Therapeutics PLC's Tax Provision growth rate?
Tax Provision CAGR 5Y
-5%
Over the last year, the Tax Provision growth was -104%. The average annual Tax Provision growth rates for Iterum Therapeutics PLC have been 6% over the past three years , -5% over the past five years .